Dr. Chang said she has received research funding from AstraZeneca, CeNeRx, Euthymics, Forest Laboratories, GlaxoSmithKline, Johnson & Johnson, and Pfizer. Some of the COMET study coauthors are employees of Bristol-Myers Squibb.
FROM THE ANNUAL MEETING OF THE NEW CLINICAL DRUG EVALUATION UNIT